Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Alembic Pharmaceuticals Ltd.
NSE: APLLTD
|
BSE: 533573
|
ISIN: INE901L01018
|
Industry: Pharmaceuticals
US FDA Approval
|
Falling Comet
849.9000
-2.05
(
-0.24
%)
NSE
Apr 17, 2025
15:31 PM
34.82% Fall from 52W High
Volume:
300.2K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alembic Pharmaceuticals Ltd.
12 Feb 2025
US FDA Approval
849.90
-0.24%
Alembic Pharma (BUY): Earnings recovery on normalised Azithromycin base
Buy:
Alembic Pharmaceuticals Ltd.
by
BOB Capital Markets Ltd.
Target: 1032 | Upside : 21.4%
Target
BOB Capital Markets Ltd.
US and ROW sales grew above our estimates of 5% and 13% respectively, reporting growth of 10% each
Alembic Pharmaceutic.. has an
average target
of 959.00 from 4 brokers.
More from Alembic Pharmaceuticals Ltd.
Recommended
Five Interesting Stocks Today - April 17, 2025
The Baseline |
17 Apr 2025, 05:29PM
Market closes higher, HDFC AMC's net profit beats Forecaster estimates by 8%
Trendlyne Marketwatch |
17 Apr 2025, 03:57PM
Earnings Call Transcript - Q1FY21 for Alembic Pharmaceuticals
|
22 Jul 2020